Marie Josephine Hoffmann

Marie Josephine Hoffmann

Auto-generated profile, based on publicly available information

Marie Josephine Hoffmann

Affiliations Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School Theodor Fontane, Bernau/Neuruppin, Germany, Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2024 in JMIR Formative Research
Verified
Journal Article
Open access
FMFelix Muehlensiepen
Felix Muehlensiepen
MHMarie Josephine Hoffmann
Marie Josephine Hoffmann
JNJonathan Nübel
Jonathan Nübel
YIYury Ignatyev
Yury Ignatyev
MHMartin Heinze
Martin Heinze
AHAnja Haase-Fielitz
Anja Haase-Fielitz
Background: In the coming years, telemedicine will play a key role in health care. Especially in rural areas with weak infrastructure, telemedicine could be crucial to providing adequate and personalized medical care. Objective: We investigated the acceptance and preferences of telemedicine among cardiologists, internists, and general practitioners. In addition, we aimed to identify knowledge, explore factors that influence the decision to adopt or reject this technology, and create starting points for demand-oriented further research. Methods: We conducted a web-based survey between May 2021 and February 2022. The 34-item questionnaire covered a wide range of questions regarding knowledge, acceptance, and use of telemedicine in cardiology care. Participants (cardiologists, internists, and general practitioners) were contacted through their professional email addresses, through a QR code published in a regional health journal, and through X (formerly known as Twitter). After exclusion of questionnaires with missed values, multidimensional scaling and k-means clustering were performed. Participants were divided into 3 clusters (C1, C2, and C3) based on their attitudes toward telecardiology. C1 uses telemedicine for personal health and clinical practice; C2 shows reluctance; C3 uses telemedicine mainly clinically. Results: We contacted 929 physicians. Of those 12.1% (112/929) completed the questionnaires. Participants were 56% male (54/97), 29% female (28/97), and 2% (2/97) diverse (median age 50 years). About 16% (18/112) of the respondents currently use telemedicine daily, 14.3% (16/112) 3-4 times a week, and 43% (48/112) did not use telemedicine at all. Overall, 35.1% (34/97) rated their knowledge of telemedicine as very good or good. Most of the respondents replied that telemedicine could support cardiology care in monitoring of blood pressure and electrocardiograms (57/97, 58.8%, both), consultation (57/97, 58.8%), and extending follow-up time (59/97, 60.8%). Reported barriers to implementation were mostly administration (26/97, 26.8%), inadequate reimbursement (25/97, 25.8%), and the purchase of technology equipment (23/97, 23.7%). Attitudes toward telemedicine in clinical practice were closely related to the number of patients being treated per annual quarter: C3 (median 1350, IQR 1000-1500) versus C1 (median 750, IQR 300-1200) and C2 (median 500, IQR 105-825). The differences between clinical caseloads of C1-C3 members were significant: C1 versus C2 (P=.03), C1 versus C3 (P=.02), and C2 versus C3 (P<.001). Most participants (87/112, 77.7%) would like to expand telemedicine approaches in the future. In the field of cardiology, the participants reported a high suitability of telemedicine. The willingness to train in telemedicine is high to very high for > 50% of the participants. Conclusions: Our results indicate generally moderate use but positive attitudes toward telemedicine among participating physicians with a higher clinical caseload. The lack of a structural framework seems to be a barrier to the effective implementation of telecardiology.

1 June 2023 in JMIR Preprints
Verified
Preprint
Open access
FMFelix Muehlensiepen
Felix Muehlensiepen
MHMarie Josephine Hoffmann
Marie Josephine Hoffmann
JNJonathan Nübel
Jonathan Nübel
YIYury Ignatyev
Yury Ignatyev
MHMartin Heinze
Martin Heinze
AHAnja Haase-Fielitz
Anja Haase-Fielitz
BACKGROUND In the coming years, telemedicine will play a key role in health care. Especially in rural areas with weak infrastructure, telemedicine could be crucial to providing adequate and personalized medical care. OBJECTIVE We investigated the acceptance and preferences of telemedicine among cardiologists, internists, and general practitioners. In addition, we aimed to identify knowledge, explore factors that influence the decision to adopt or reject this technology, and create starting points for demand-oriented further research. METHODS We conducted a web-based survey between May 2021 and February 2022. The 34-item questionnaire covered a wide range of questions regarding knowledge, acceptance, and use of telemedicine in cardiology care. Participants (cardiologists, internists, and general practitioners) were contacted through their professional email addresses, through a QR code published in a regional health journal, and through X (formerly known as Twitter). After exclusion of questionnaires with missed values, multidimensional scaling and k-means clustering were performed. Participants were divided into 3 clusters (C1, C2, and C3) based on their attitudes toward telecardiology. C1 uses telemedicine for personal health and clinical practice; C2 shows reluctance; C3 uses telemedicine mainly clinically. RESULTS We contacted 929 physicians. Of those 12.1% (112/929) completed the questionnaires. Participants were 56% male (54/97), 29% female (28/97), and 2% (2/97) diverse (median age 50 years). About 16% (18/112) of the respondents currently use telemedicine daily, 14.3% (16/112) 3-4 times a week, and 43% (48/112) did not use telemedicine at all. Overall, 35.1% (34/97) rated their knowledge of telemedicine as very good or good. Most of the respondents replied that telemedicine could support cardiology care in monitoring of blood pressure and electrocardiograms (57/97, 58.8%, both), consultation (57/97, 58.8%), and extending follow-up time (59/97, 60.8%). Reported barriers to implementation were mostly administration (26/97, 26.8%), inadequate reimbursement (25/97, 25.8%), and the purchase of technology equipment (23/97, 23.7%). Attitudes toward telemedicine in clinical practice were closely related to the number of patients being treated per annual quarter: C3 (median 1350, IQR 1000-1500) versus C1 (median 750, IQR 300-1200) and C2 (median 500, IQR 105-825). The differences between clinical caseloads of C1-C3 members were significant: C1 versus C2 (P=.03), C1 versus C3 (P=.02), and C2 versus C3 (P<.001). Most participants (87/112, 77.7%) would like to expand telemedicine approaches in the future. In the field of cardiology, the participants reported a high suitability of telemedicine. The willingness to train in telemedicine is high to very high for > 50% of the participants. CONCLUSIONS Our results indicate generally moderate use but positive attitudes toward telemedicine among participating physicians with a higher clinical caseload. The lack of a structural framework seems to be a barrier to the effective implementation of telecardiology.

20 April 2026 in PLOS Digital Health
Verified
Journal Article
Open access
PDF file
Pascal PETITPascal PETIT
Pascal PETIT
JNJonathan Nübel
Jonathan Nübel
MWMarie Josephine Walter
Marie Josephine Walter
CBChristian Butter
Christian Butter
MHMartin Heinze
Martin Heinze
FMFelix Muehlensiepen
Felix Muehlensiepen
In this secondary analysis of a German cross-sectional survey data, we investigated key determinants and predictors of telemedicine (TM) use among healthcare professionals (HCPs) treating cardiology patients. We applied Bayesian Model Averaging (BMA) for explanatory analysis and Machine Learning (ML) for predictive modeling. BMA identified TM determinants after excluding collinear variables and selecting variables based on LASSO regression. The extreme gradient boosting (XGBoost) ML algorithm predicted TM use and identified key predictors, using nested cross-validation to prevent overfitting. ML model performance was assessed via area under the receiver operating characteristic curve (AUROC), while predictor importance was evaluated using Shapley additive explanations. Among 112 HCPs, 64 (57%) used TM. BMA identified 12 determinants, including positive associations with TM knowledge, being a cardiologist, female gender, and perceiving TM as suitable for heart failure and for monitoring events. Negative associations included concerns about insufficient patient benefits, perceptions that TM is less suitable for acute events, and skepticism regarding its relevance for extending aftercare intervals. The XGBoost model showed strong predictive performance (AUROC: 0.88 [95% CI: 0.75; 1.00], accuracy: 0.79) for TM use. Key promoting factors included TM knowledge, being a cardiologist, female gender, number of average patients per quarter, and perceiving TM as suitable for arrhythmias, device follow-up, and heart failure. Limiting factors included older age, personal use of TM for one’s own health, and skepticism about TM’s relevance in acute situations. These findings emphasize the importance of knowledge and attitudes in shaping TM adoption and show that ML can accurately identify healthcare professionals most likely to use TM, supporting targeted interventions and safer implementation in cardiology.